Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Alecxih currently holds 278,371 shares of NEVRO CORP (NVRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Alecxih has been a net neutral trader of NVRO stock. They have purchased $0 and sold $0 worth of shares.
James Alecxih's most recent insider trade was on Oct 24, 2019, when they sold 240,000 shares at $0.00 per share.
James Alecxih serves as Executive at NEVRO CORP (NVRO). They have executed 3 insider transactions totaling $0 over their tenure at the company.
James Alecxih holds the position of Executive at NEVRO CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
James Alecxih has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by James Alecxih was on Oct 24, 2019, when they purchased $0 worth of VRAY shares. This transaction involved 240,000 shares at N/A per share.
James Alecxih currently owns 278,371 shares of NEVRO CORP (NVRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Alecxih's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Alecxih has 3 Form 4 filings on record as an insider at NEVRO CORP.
Set alerts for James Alecxih and 40,000+ other insiders.